These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 650932)

  • 1. [Fibrinolytic changes in subarachnoid hemorrhage and anti-fibrinolytic therapy--application of an anti-plasmin agent (t-AMCHA)].
    Watanabe H; Ishii S; Chigasaki H
    Nihon Rinsho; 1978; 36(3):555-62. PubMed ID: 650932
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
    Watanabe H; Ito M; Chigasaki H; Ishii S
    Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
    [No Abstract]   [Full Text] [Related]  

  • 3. Antifibrinolytic therapy in subarachnoid hemorrhage.
    Jordan KG
    N Engl J Med; 1985 Jan; 312(1):52-3. PubMed ID: 3880594
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of Arthus tonsillitis by the administration of an antiplasminic agent.
    Kosugi T; Takagi I; Kinjo K; Nakagawa S; Noda Y; Mihara H
    Int J Tissue React; 1983; 5(2):205-15. PubMed ID: 6225744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
    Fodstad H
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
    Schisano G
    Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
    Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
    Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Preoperative management of patients with aneurysmal subarachnoid haemorrhage. A preliminary comparative study of consecutive and randomized series.
    Tovi D
    Acta Neurochir (Wien); 1975; 31(3-4):271. PubMed ID: 1181836
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rapid measurement of fibrinolytic activity in CSF by t-AMCA score method. Correlation with concentration of antifibrinolytic agent in CSF (author's transl)].
    Nishimatsu T; Shibasaki T; Sasaki H; Nukui H; Kawafuchi J; Okada K
    Rinsho Byori; 1980 Mar; 28(3):265-70. PubMed ID: 7373890
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolytic inhibitors for acute gastric haemorrhage.
    Br Med J; 1977 Dec; 2(6102):1565-6. PubMed ID: 303927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possibilities of the use of an inhibitor of hemolysis (AMCHA), by rectal and vaginal administration, for gynecological hemorrhages].
    Valsecchi A; Cappelletti M
    Minerva Ginecol; 1975 Apr; 27(4):339-47. PubMed ID: 1169724
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
    Fodstad H; Nilsson IM
    Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy.
    Woo KS; Tse LK; Woo JL; Vallance-Owen J
    Br J Clin Pract; 1989 Dec; 43(12):465-6. PubMed ID: 2611113
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of gingival hemorrhage in hemophilic patients by inhibition of fibrinolysis with tranexamic acid.
    Sindet-Pedersen S; Stenbjerg S; Ingerslev J
    J Periodontal Res; 1988 Jan; 23(1):72-4. PubMed ID: 2963908
    [No Abstract]   [Full Text] [Related]  

  • 17. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
    Tovi D
    J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of fibrinolysis inhibitor and chemotherapeutics on the growth of human cancers transplanted into nude mice and in tissue culture.
    Iwakawa A; Tanaka K
    Invasion Metastasis; 1982; 2(4):232-48. PubMed ID: 7188396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
    van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H
    Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.
    Fodstad H; Thulin CA
    Acta Neurochir (Wien); 1980; 54(1-2):127-31. PubMed ID: 7435290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.